Cargando…

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer

Background: The tumor immune microenvironment (TIME) plays an important role in the development and prognosis of bladder cancer. It is essential to conduct a risk model to explore the prognostic value of the immunologic genes and establish an individualized prognostic signature for predicting the su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qing, Wang, Yunchao, Gao, Huayu, Sun, Fahai, Wang, Xuan, Zhang, Huawei, Wang, Jianning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002098/ https://www.ncbi.nlm.nih.gov/pubmed/35422849 http://dx.doi.org/10.3389/fgene.2022.837301

Ejemplares similares

Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2021)

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer
por: He, Yang, et al.
Publicado: (2022)

Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer
por: Zhong, Wenwen, et al.
Publicado: (2022)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2022)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

Identification of a Twelve-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival for Medulloblastoma
por: Zhu, Sihan, et al.
Publicado: (2020)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)

Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer
por: Zheng, Zhenming, et al.
Publicado: (2021)

Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients
por: Bai, Yiyang, et al.
Publicado: (2020)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM
por: Cheng, Quan, et al.
Publicado: (2019)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma
por: Pan, Mengmeng, et al.
Publicado: (2021)

Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature
por: Sun, Zepang, et al.
Publicado: (2020)

A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer
por: Zhang, Xiaolu, et al.
Publicado: (2021)

Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
por: Jin, Yi, et al.
Publicado: (2022)

Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
por: Jiang, Kan, et al.
Publicado: (2022)

SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
por: Liu, Fangshu, et al.
Publicado: (2023)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer
por: Yu, Lili, et al.
Publicado: (2023)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
por: He, Yi, et al.
Publicado: (2023)

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
por: Tao, Yuting, et al.
Publicado: (2022)

Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer
por: Wu, Yucai, et al.
Publicado: (2020)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2021)

Stromal Score-Based Gene Signature: A Prognostic Prediction Model for Colon Cancer
por: Jia, Jing, et al.
Publicado: (2021)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
por: Liu, Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_khf0meac2je7l97msskejjioqv